HUBEI HONGYUAN PHAHUBEI HONGYUAN PHAHUBEI HONGYUAN PHA

HUBEI HONGYUAN PHA

No trades
See on Supercharts

301246 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Hubei Hongyuan Pharmaceutical Technology Co., Ltd. principally engages in the research, development, production, and sale of organic chemical raw materials, pharmaceutical intermediates, raw materials, and pharmaceutical preparations. It also produces lithium hexafluorophosphate, one of the main materials of lithium battery electrolytes. Its key products include organic chemical raw materials, pharmaceutical intermediates, raw materials, and pharmaceutical preparations in the ethylene glycol reaction chain as well as pharmaceutical intermediates in the reaction chain of methyl cyanoacetate and guanidine hydrochloride. The company was founded by Guo Ping Yin on January 21, 2002 and is headquartered in Huanggang, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

301246 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company